[Hypotensive effects of timolol in 86 patients (author's transl)]. 1978

G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot

Antihypertensive action of timolol (MK 950) was studied in 86 outpatients with essential, uncomplicated hypertension. Timolol is an effective hypotensive drug with significant lowering pressor effect. Timolol was given alone in 53 cases and in association with other hypotensive drugs in 33 cases: the mean dose was 20 mg daily for 8 months. At the end of treatment the mean diastolic pressure recumbert, standing, and after exercise had decreased by 10.2, 9.2 and 11 mmHg. Cardiac frequency had decreased by 13, 24 and 29 p. min lying, standing and after exercise. Side effects were rare, with cessation of treatment only in 4 cases.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
December 1978, Journal francais d'ophtalmologie,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
November 1979, Journal francais d'ophtalmologie,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
March 1982, Ceskoslovenska oftalmologie,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
April 1980, Klinische Monatsblatter fur Augenheilkunde,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
May 1980, Klinische Monatsblatter fur Augenheilkunde,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
October 1974, Medizinische Klinik,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
October 1981, Klinische Monatsblatter fur Augenheilkunde,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
August 1980, Archives of ophthalmology (Chicago, Ill. : 1960),
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
January 1982, Journal francais d'ophtalmologie,
G Lagrue, and A Gumpelson, and M Kazandjan, and A Grillot
April 1982, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!